Results 21 to 30 of about 23,620 (204)

Ascorbate and Antibiotics, at Concentrations Attainable in Urine, Can Inhibit the Growth of Resistant Strains of Escherichia coli Cultured in Synthetic Human Urine

open access: yesAntibiotics, 2023
There are conflicting reports on the antibacterial activity of ascorbate; all at concentrations much higher than the typical in human plasma, but that can be reached in urine.
Carlos F. Amábile-Cuevas
doaj   +1 more source

A Combined Experimental and Theoretical Study of Nitrofuran Antibiotics: Crystal Structures, DFT Computations, Sublimation and Solution Thermodynamics

open access: yesMolecules, 2021
Single crystal of furazolidone (FZL) has been successfully obtained, and its crystal structure has been determined. Common and distinctive features of furazolidone and nitrofurantoin (NFT) crystal packing have been discussed.
Alex N. Manin   +4 more
doaj   +1 more source

Analysis of WHONET Surveillance Data of Antimicrobial Sensitivity of Uropathogens in a Tertiary Care Hospital: An Indicator to Empirical Antimicrobial Treatment for Urinary Tract Infection [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Introduction: Urinary Tract Infections (UTIs) are among the most common bacterial infections. A regular surveillance of local aetiology and susceptibility profile could support the most effective empirical treatment. WHONET (World Health Organisation
Vandana A Agarwal   +3 more
doaj   +1 more source

Assessing the urinary concentration of nitrofurantoin and its antibacterial activity against Escherichia coli, Staphylococcus pseudintermedius, and Enterococcus faecium isolated from dogs with urinary tract infections

open access: yesFrontiers in Veterinary Science, 2023
Nitrofurantoin, a broad-spectrum nitrofuran class antibiotic, is applied as a first-line antibiotic in treating human urinary tract infections (UTIs) due to its great efficacy and high achievable concentration.
Chien-Che Hung   +11 more
doaj   +1 more source

A new approach in treatment of chronic murine models of toxoplasmosis using nitrofurantoin antibiotic. [PDF]

open access: yesZagazig University Medical Journal, 2022
Background: Standard therapies for toxoplasmosis have serious adverse effects and can’t eliminate cyst stage of chronic infection. Highly effective medications with few adverse effects are required.Objective: To determine the efficacy of nitrofurantoin ...
Karim Abdallah   +5 more
doaj   +1 more source

Beyond Expert Opinion: A Comparison of Antibiotic Regimens for Infectious Urinary Tract Pathology in Pregnancy

open access: yesAmerican Journal of Perinatology Reports, 2020
Objective Outside pregnancy, nitrofurantoin, ciprofloxacin and sulfamethoxazole-trimethoprim (SMZ-TMP) are first-line therapy (FLT) for lower urinary tract infections (LUTIs).
Madison K. Krischak   +6 more
doaj   +1 more source

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women

open access: yesBiomedicines, 2023
In this study, we compared the failure rates of fosfomycin and nitrofurantoin for uncomplicated urinary tract infections. We used Meuhedet Health Services’ large database to collect data on all female patients, older than 18 years, who were prescribed ...
Asher Shafrir   +3 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

A Combination of Virtual and Experimental Screening Tools for the Prediction of Nitrofurantoin Multicomponent Crystals with Pyridine Derivatives

open access: yesCrystals, 2023
Thirty-four binary systems of nitrofurantoin with pyridine derivatives were analyzed by combining virtual (molecular complementarity prediction and hydrogen bond propensity calculations) and experimental (liquid-assisted grinding) screening methods.
Alex N. Manin   +5 more
doaj   +1 more source

PHYSICOCHEMICAL AND PHARMACOKINETIC CHARACTERIZATION OF NITROFURANTOIN.

open access: yes, 1980
PHYSICOCHEMICAL AND PHARMACOKINETIC CHARACTERIZATION OF ...
KRISHNA SRINIVAS. VISHNUPAD (7986428)
core   +4 more sources

Home - About - Disclaimer - Privacy